Department news | April 21, 2022
A growing body of research suggests that the use of psychedelic compounds combined with behavioral interventions may provide powerful treatment options for a range of addictions including alcohol use disorder, opioid use disorder, tobacco use disorder and others.
Department news | April 21, 2022
Amritha Bhat, MBBS, MD, MPH, received the Translational Research Partnership Award for Academic Community Partnerships for her project “Perinatal Mood and Anxiety Disorders: Building the Capacity of Birth Doulas to Improve Access to Care and Outcomes for Parents and Babies.”
Department news | April 21, 2022
Erin Schoenfelder Gonzalez, PhD, received a grant for “Parent Behavior Management Training for Foster Caregivers”, and Myra Parker, JD, PhD, received a grant for “STIM A SPU’US - “What’s in Your Heart”: A Culturally Adapted, Trauma Informed Parenting Intervention for the Colville Tribes.
Department news | April 21, 2022
We are delighted to announce the recipients of the Department’s Suicide Prevention and Recovery Small Grants Program aimed at supporting projects related to preventing suicide, promoting the recovery of suicide survivors and supporting the families and caregivers impacted by suicide.
UW Medicine newsroom | May 2, 2022
Emily Dworkin, PhD, talks about how the CARES Program teaches the people around survivors of sexual assault the skills to provide effective support. This story was covered in multiple outlets including Northwest News Radio and The Seattle Times.
ARDC News | March 17, 2022
Debby Tsuang, MD, MSc, and her team are researching the best remote health tools to assess mental health symptoms for African Americans and better include them in research. Written by Lori Mae Yvette Calibuso Acob, Brain Health Science Writing intern at the Garvey Institute for Brain Health Solutions.
The Seattle Times | January 5, 2022
A new Center for Medication Development for Substance Use Disorders led by Marco Pravetoni, PhD, will focus on developing vaccines against addiction and other novel addiction therapies. The story was covered by multiple media outlets including The Spokesman-Review, FOX 13, and KOMO Radio.
CBS Evening News | January 12, 2022
Tackling the opioid crisis requires changing strategies and the way we think about addiction. Marco Pravetoni, PhD, and his colleagues at Columbia University are working on a vaccine that targets the chemical makeup of oxycodone.
Spectrum | June 29, 2015
Raphael Bernier, PhD, associate professor of psychiatry at the University of Washington in Seattle conducted an in-depth look at people with alterations in the 1q21.1 chromosomal region to reveal a range of features, from problems with fine motor skills to autism.
The Seattle Times | December 16, 2021
Repeated exposure to sickness and death, and a sense of fear and anxiety that’s rippled across the medical and first-responder communities during the pandemic, is crippling the mental well-being of many people in these vital workforces, according to a new study led by Rebecca Hendrickson, MD, PhD.
